Rchr
J-GLOBAL ID：200901035523672122   Update date: Aug. 30, 2024

Yamamoto Yutaka

ヤマモト ユタカ | Yamamoto Yutaka
Affiliation and department：
Kumamoto University University Hospital, Department of Breast and Endocrine Surgery

About Kumamoto University University Hospital, Department of Breast and Endocrine Surgery


Job title： Professor
Homepage URL  (1)： http://www2.kuh.kumamoto-u.ac.jp/breast/
Research field  (1)： General surgery, pediatric surgery
Research keywords  (3)： clinical trials ,  乳癌の生物学的因子 ,  Biological factors for breast cancer
Research theme for competitive and other funds  (5)：
  • 2014 - 2017 Detection for predictive factors of estrogen addition and depletion therapy in endocrine therapy-resistant breast cancer
  • 2012 - 2015 Development of quantitative evaluation tool using multigene expression to predict efficacy of endocrine therapy for breast cancer
  • 2012 - 2015 The role of MACC1 in breast cancer
  • 2009 - 2011 Study for mechanism of cell cycle regulation by ubiquitin ligase in triple-negative breast cancer
  • 2007 - 2008 The study on the sensitization of transcriptional modulator to endocrine therapy for breast cancer
Papers (175)：
  • Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai, Takehiko Sakai, Goro Kutomi, Michio Yoshimura, Masaaki Kawai, Shoichiro Ohtani, Kazunori Kubota, et al. Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast cancer (Tokyo, Japan). 2024
  • Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai, Takehiko Sakai, Goro Kutomi, Michio Yoshimura, Masaaki Kawai, Shoichiro Ohtani, Kazunori Kubota, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast cancer (Tokyo, Japan). 2024. 31. 3. 340-346
  • T. Takeshita, T. Iwamoto, N. Niikura, K. Watanabe, Y. Kikawa, K. Kobayashi, N. Iwakuma, T. Okamura, H. Tada, S. Ozaki, et al. Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing. ESMO Open. 2024. 9. 4
  • Masaya Hattori, Naoko Honma, Shigenori Nagai, Kazutaka Narui, Tomoko Shigechi, Yukinori Ozaki, Masayuki Yoshida, Takashi Sakatani, Eiichi Sasaki, Yuko Tanabe, et al. Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines. Breast cancer (Tokyo, Japan). 2024
  • Ian E. Krop, Norikazu Masuda, Toru Mukohara, Shunji Takahashi, Takahiro Nakayama, Kenichi Inoue, Hiroji Iwata, Yutaka Yamamoto, Ricardo H. Alvarez, Tatsuya Toyama, et al. Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial. Journal of Clinical Oncology. 2023. 41. 36. 5550-5560
ｍore...
MISC (362)：
  • 菰原義弘, 新地祐介, 米満侯宏, 藤原章雄, 山本豊, 鈴木実. The mechanisms of PD-L1 overexpression in tumor associated macrophages (TAMs) in lung and breast cancers. 日本癌学会学術総会抄録集(Web). 2022. 81st
  • Akihiko Shimomura, Masayuki Nagahashi, Hiraku Kumamaru, Yutaka Yamamoto, Hiromitsu Jinno, Shigeru Imoto. Clinicopathological characteristics of male breast cancer in Japan from the national clinical database. CANCER RESEARCH. 2021. 81. 4
  • Yutaka Yamamoto, Hiroji Iwata, Taira Naruto, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, et al. A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study. CANCER RESEARCH. 2021. 81. 4
  • 稲尾瞳子, 日高香織, 藤川和晃, 後藤理沙, 冨口麻衣, 末田愛子, 山本豊. 術前診断が困難であった甲状腺充実型乳頭癌の一例. 乳腺甲状腺超音波医学. 2021. 10. 4
  • 安立 弥生, 麻賀 創太, 隈丸 拓, 山本 豊, 神野 浩光. NCD乳癌登録を用いたInvasive lobular carcinomaのサブタイプ別の予後に関する研究. 日本乳癌学会総会プログラム抄録集. 2020. 28回. 49-49
ｍore...
Books (18)：
  • 乳腺腫瘍学 第3版
    金原出版 2020 ISBN:9784307204088
  • 領域横断的がん取扱い規約
    金原出版 2019 ISBN:9784307004862
  • 臨床・病理乳癌取扱い規約
    金原出版 2018 ISBN:9784307203869
  • 乳がん薬物療法ハンドブック
    南江堂 2018
  • 乳がん薬物療法副作用マネジメント プロのコツ
    メディカルレビュー社 2017
ｍore...
Lectures and oral presentations  (111)：
  • 地震災害から得られた教訓 -乳癌診療を通じて-
    (第18回日本臨床腫瘍学会学術集会 2021)
  • Optimal sequential endocrine treatment with targeted therapies in postmenopausal ER-positive/HER2-negative advanced breast cancer
    (KYOTO BREAST CANCER CONSENSUS CONFERENCE 2021 2021)
  • A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study
    (43rd Annual San Antonio Breast Cancer Symposium 2020)
  • Pooled-analysis of prospective observational studies evaluated the effectiveness and safety of bevacizumab and paclitaxel as the first-line chemotherapy for HER2-negative metastatic breast cancer.
    (2020)
  • 乳癌におけるリキッドバイオプシーの現状と将来展望
    (第32回日本内分泌外科学会総会 2020)
ｍore...
Works (1)：
  • 転写モジュレーターによる乳癌内分泌療法の効果増強に関する研究
    2007 - 2008
Education (1)：
  • 1985 - 1991 Miyazaki Medical College Department of Medicine
Professional career (1)：
  • Doctor of Medicine (Kumamoto University)
Work history (12)：
  • 2022/04 - 現在 Kumamoto University Hospital Department of Breast and Endocrine Surgery Professor
  • 2021/10 - 現在 Graduate School of Medical Sciences, Kumamoto University Department of Respiratory Surgery and Breast Surgery Associate Professor
  • 2015/04 - 2021/10 Graduate School of Medical Sciences, Kumamoto University Department of Breast and Endocrine surgery Associate Professor
  • 2012 - 2015 熊本大学医学部附属病院乳癌分子標的治療学寄附講座 寄附講座教員
  • 2015 - Kumamoto University Faculty of Life Sciences
Show all
Committee career (23)：
  • 2024/08 - 現在 Japan Surgical Society A committee member of the Academic Committee
  • 2020/04 - 現在 Japan Sugical Society Councilor
  • 2014 - 現在 Japan Breast Cancer Research Group 理事
  • 2024/08 - 2025/07 Japanese Breast Cancer Society Board of Director
  • 2022/07 - 2024/11 Japanese Breast Cancer Society Chair of the Clinical Practice Guidelines Committee
Show all
Association Membership(s) (2)：
日本乳癌学会 ,  The Japanese Breast Cancer Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM